Synarel Spray, Metered
Product Images NDC 0025-0166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Synarel (NDC 0025-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Synarel 01)

Chemical Structure (Synarel 01)
Chemical structure of nafarelin acetate, the active ingredient in Synarel nasal spray 2 mg/mL by Pfizer Laboratories Div Pfizer Inc. The image depicts the molecular formula with amino acid residues and characteristic side chains of this synthetic decapeptide.*
FDA Label Image

Logo (Synarel 02)

FDA Label Image

Chemical Structure (Synarel 03)

Chemical Structure (Synarel 03)
Chemical structure of nafarelin acetate, the active ingredient in Synarel nasal spray. The diagram shows the molecular arrangement of atoms and bonds representing the peptide structure of nafarelin acetate.*
FDA Label Image

Figure (Synarel 04)

Figure (Synarel 04)
A horizontal bar chart depicting the percentage of patients experiencing adverse events during 6 months of treatment with Synarel 400 mcg/day versus Danazol 600 or 800 mg/day. The chart lists adverse events such as hot flashes, libido decreased, vaginal dryness, headaches, emotional lability, insomnia, acne, myalgia, breast size reduced, edema, seborrhea, weight gain, hirsutism, libido increased, nasal irritation, depression, and weight loss. Bars represent the incidence rates for Synarel and Danazol patient groups.*
FDA Label Image

Logo (Synarel 05)

FDA Label Image

Figure A (Synarel 06)

Figure A (Synarel 06)
An instructional illustration showing the components of a Synarel nasal spray dispenser. The diagram labels the clear dust cover, spray tip, shoulders, white safety clip, and the preassembled nasal pump spray dispenser attached to a bottle.*
FDA Label Image

Figure B (Synarel 07)

Figure B (Synarel 07)
Illustration showing a step in assembling or preparing a nasal spray device. It depicts a hand pressing or holding a part of the device, with arrows indicating an upward and forward motion to attach or adjust components.*
FDA Label Image

Figure C (Synarel 08)

Figure C (Synarel 08)
An instructional illustration depicting a hand holding a nasal spray bottle with liquid spraying out from the nozzle. The image shows proper usage of a metered nasal spray, likely representing the administration method for Synarel (nafarelin acetate) nasal spray.*
FDA Label Image

Figure D (Synarel 09)

Figure D (Synarel 09)
An instructional diagram showing a person using their hand to press down and lock a nasal spray pump mechanism. The image illustrates the correct technique to prepare the spray for use by pressing the pump downwards with the fingers.*
FDA Label Image

Figure E (Synarel 10)

Figure E (Synarel 10)
An instructional illustration showing a person holding a nasal spray device with both hands and inserting it into the nostrils. The image demonstrates the correct positioning of the spray for nasal administration.*
FDA Label Image

Figure F (Synarel 11)

Figure F (Synarel 11)
An instructional illustration showing how to operate a nasal spray. It depicts a hand pressing down on the pump mechanism to release the spray, with arrows indicating the upward and forward motion required for use.*
FDA Label Image

Figure G (Synarel 12)

Figure G (Synarel 12)
An instructional illustration showing a person using a nasal spray device. The person is holding the spray bottle close to their nostril and appears to be administering the spray intranasally.*
FDA Label Image

Figure H (Synarel 13)

Figure H (Synarel 13)
An instructional illustration showing a person using a nasal metered spray. The person holds the spray bottle near one nostril with one hand and uses the other hand to close the opposite nostril, demonstrating proper technique for nasal administration.*
FDA Label Image

Figure I (Synarel 14)

Figure I (Synarel 14)
An illustration depicting a side profile of a woman's face tilted upward, demonstrating the angle for nasal spray administration. The image is likely instructive for proper use of Synarel nasal spray.*
FDA Label Image

Figure J (Synarel 15)

Figure J (Synarel 15)
An instructional illustration showing how to assemble or activate a nasal spray device. It depicts one hand holding the pump and another hand pressing a component down and inward, indicated by arrows, to prepare the spray for use.*
FDA Label Image

Logo (Synarel 16)

FDA Label Image

Figure A (Synarel 17)

Figure A (Synarel 17)
An instructional diagram of a Synarel nasal spray dispenser labeled with key parts: clear dust cover, spray tip, shoulders, white safety clip, and preassembled nasal pump dispenser. The image shows the spray device broken down for user understanding.*
FDA Label Image

Figure B (Synarel 18)

Figure B (Synarel 18)
An instructional illustration showing how to assemble or prepare a nasal spray device. It depicts a hand holding the base of the spray with a finger pointing to slide or lock the top part in an upward and forward direction, indicating the proper method for securing the nozzle on the nasal spray.*
FDA Label Image

Figure C (Synarel 19)

Figure C (Synarel 19)
An instructional illustration showing a person holding a nasal spray bottle with a finger pressing the top to release a metered spray. The image demonstrates proper use of the spray nozzle, with multiple droplets depicted spraying outward.*
FDA Label Image

Figure D (Synarel 20)

Figure D (Synarel 20)
An instructional illustration showing a water faucet running and being used to rinse or clean the nozzle of a metered nasal spray bottle. The image emphasizes proper cleaning of the spray nozzle.*
FDA Label Image

Figure E (Synarel 21)

Figure E (Synarel 21)
An instructional illustration showing a hand positioning a nasal spray bottle with one finger pushing down on the top of the spray and another hand stabilizing the bottle's base, with arrows indicating the direction to press and stabilize for use.*
FDA Label Image

Figure F (Synarel 22)

Figure F (Synarel 22)
An instructional diagram showing a person inserting fingers into their nostrils, likely illustrating the correct technique for nasal spray administration.*
FDA Label Image

Figure G (Synarel 23)

Figure G (Synarel 23)
An instructional diagram showing a hand removing the nasal spray applicator from the spray bottle by pulling upwards, then pointing the spray horizontally. This image likely illustrates part of the usage or assembly instructions for Synarel nasal spray.*
FDA Label Image

Figure H (Synarel 24)

Figure H (Synarel 24)
An instructional line drawing showing a person using a nasal spray. The individual is tilting their head slightly back while another hand holds and inserts a nasal spray device into their nostril, demonstrating proper administration technique.*
FDA Label Image

Figure I (Synarel 25)

Figure I (Synarel 25)
An instructional illustration shows a person using a nasal spray. The person tilts their head slightly back and inserts a metered nasal spray applicator into one nostril while holding the bottle with the other hand. The image guides proper nasal spray administration technique.*
FDA Label Image

Figure J (Synarel 26)

Figure J (Synarel 26)
An illustration showing a woman's side profile with her head tilted back, demonstrating the correct position for using a nasal spray.*
FDA Label Image

Figure K (Synarel 27)

Figure K (Synarel 27)
An instructional illustration demonstrating the preparation of a nasal spray device. The image shows a hand pressing down on the spray pump while another hand holds the base, with arrows indicating the direction of pressing and locking the spray mechanism.*
FDA Label Image

Logo (Synarel 28)

FDA Label Image

Principal Display Panel (8 mL Bottle Label)

Principal Display Panel (8 mL Bottle Label)
Packaging label for Synarel nasal spray by Pfizer Laboratories, containing nafarelin acetate nasal solution at 2 mg/mL strength. The 8 mL metered spray delivers approximately 200 mcg per actuation. The label includes storage instructions, dosage form, and distributor information, including Pfizer Inc, NY, NY.*
FDA Label Image

Principal Display Panel (8 mL Bottle Carton)

Principal Display Panel (8 mL Bottle Carton)
Label for Synarel nasal solution spray, 2 mg/mL nafarelin acetate (as nafarelin base). The label shows an 8 mL bottle containing 60 metered sprays for intranasal use, distributed by Pfizer Laboratories Division Pfizer Inc. It includes dosage delivery details and storage instructions, with the Pfizer logo prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.